Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

3.35USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$3.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,464
52-wk High
$9.69
52-wk Low
$3.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 8.35 -0.114
Jun '18 11.69 -0.004
Mar '18 4.15 -0.174
FY 2017 Dec '17 18.15 0.167
Sep '17 3.93 -0.159
Jun '17 1.85 -0.232
Mar '17 1.34 -0.186
FY 2016 Dec '16 2.73 -0.152
Sep '16 0.79 -0.144
Jun '16 1.07 -0.144
Mar '16 1.25 -0.104
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 7.03 8.80 4.51 0.00
Quarter Ending Mar-19 2 6.25 6.70 5.80 --
Year Ending Dec-18 5 31.22 33.00 28.70 12.56
Year Ending Dec-19 5 23.79 31.00 12.00 11.97
Earnings (per share)
Quarter Ending Dec-18 5 -0.15 -0.12 -0.20 -0.12
Quarter Ending Mar-19 1 -0.18 -0.18 -0.18 --
Year Ending Dec-18 5 -0.47 -0.41 -0.56 -0.64
Year Ending Dec-19 5 -0.80 -0.62 -1.07 -0.74
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 41.16 49.58 6.22
Price to Book (MRQ) 29.26 10.17 5.20
Price to Tangible Book (MRQ) 29.57 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 50.96 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 72.70 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 37.63 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -61.36 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -69.16 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 2.87 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -92.13 -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -417.27 -- --
EBITD - 5 Yr. Avg -- -109.98 13.16
Operating Margin (TTM) -424.61 -185.00 6.07
Operating Margin - 5 Yr. Avg. -- -126.42 8.47
Pre-Tax Margin (TTM) -445.15 -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.71
Net Profit Margin (TTM) -459.70 -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 136,884 7,649,006 873,053,182
Net Income/Employee (TTM) -629,254 653,334 103,483,965
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.09 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.46 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -55.96 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -132.26 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.41 17.37
  1 Year 3 Year 5 Year
Sales % 98.87 -22.30 --
EPS (TTM) % -33.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pieris Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 16.89 12.86 78 98
13 Week 7.41 2.18 61 94
26 Week 162.87 142.89 97 98
52 Week 264.33 208.80 96 68
YTD 343.35 289.35 98 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.08%
# of Holders: 140
Total Shares Held: 36,322,073
3 Mo. Net Change: 457,817
# New Positions: 16
# Closed Positions: 23
# Increased Positions: 64
# Reduced Positions: 63
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.